CDRH Compliance Office Looks Ahead To 2016
This article was originally published in The Gray Sheet
Executive Summary
More emphasis on informal interactions with companies for minor concerns will be one hallmark of the FDA device center's Office of Compliance agenda for the coming year, according to Acting Director Sean Boyd, who provided an overview of the office's 2016 priorities.